QIAGEN NV (NASDAQ:QGEN)
21.95
+0.59 (2.76%)
| QIAGEN NV (NASDAQ:QGEN) Delayed : | |||||
|---|---|---|---|---|---|
| Previous Close | $21.36 | 52 Week High | $23.58 | ||
| Open | $21.64 | 52 Week Low | $14.32 | ||
| Day High | $22.04 | P/E | N/A | ||
| Day Low | $21.60 | EPS | $0.00 | ||
| Volume | 1,338,390 | ||||
| More QGEN Info: Chart SEC Filings Profile Historical Options | |||||
What is this?Friends, Peers and Foes
| Ticker | # Stories | Ticker | # Stories |
|---|---|---|---|
| LIFE | 5 | GE | 5 |
| EVVV | 5 | ARM | 5 |
| CHK | 4 | HOT | 4 |
| PL | 4 | ACM | 4 |
| LFT | 4 | VET.UN | 4 |
| ASR | 4 | FRA | 4 |
Entities who have mentioned QGEN
- Jefferies & Co | View Related Stories »
- Credit Suisse | View Related Stories »
- HSBC | View Related Stories »
- UBS | View Related Stories »
- Dividend | View Related Stories »
- Citi | View Related Stories »
- Barclays | View Related Stories »
- Cowen & Co | View Related Stories »
- Harbinger Capital | View Related Stories »
- Goldman Sachs | View Related Stories »
- Deutsche Bank | View Related Stories »
- Morgan Stanley | View Related Stories »
- JPMorgan | View Related Stories »
- StreetInsider.com Morning Movers | View Related Stories »
- Trading Radar | View Related Stories »
- Vanguard | View Related Stories »
- Life, Style and Real Estate | View Related Stories »
- Goldman Sachs Conviction Buy List | View Related Stories »
- Brean Murray Carret & Co. | View Related Stories »
- Cantor Fitzgerald | View Related Stories »
- Robert W Baird | View Related Stories »
- BMO Capital | View Related Stories »
- BWS Financial | View Related Stories »
- Janney Montgomery Scott | View Related Stories »
- Notable Analyst Rating Changes | View Related Stories »
View All Major News StreetInsider.com Major News for QGEN
- Qiagen NV (QGEN) Posts Q3 EPS of $0.26, Tops by 3c; Raises FY09 EPS
- Qiagen (QGEN) Tops Q2 View By 3c; Raises Guidance
- QIAGEN (QGEN) Reports Q1 Adj-EPS of $0.20, Beats by 1c
View All ReportsStreetInsider.com Reports on QGEN
- Qiagen NV (QGEN) Posts Q3 EPS of $0.26, Tops by 3c; Raises FY09 EPS
- Trading Radar for 11/10: Tyco Int. (TYC), ArvinMeritor (ARM), Clearwire (CLWR), American Apparel (APP) Report
- Cowen & Co Initiates Coverage on Qiagen (QGEN) with an Outperform
- Barclays Initiates Coverage on Qiagen (QGEN) with an Overweight
- QIAGEN (QGEN) Announces Underwriters Exercise Over-Allotment Option for 4.125M Shares
View All Press ReleasesCompany Press Releases on QGEN
- 2010 IR Global Rankings: Invitation for Investors and Analysts Vote for Companies with the Best IR Program and for the Best IR Officer
- Xenomics, Inc. and Its Subsidiary TrovaGene, Inc. Announce HPV Patent Filing Based on Transrenal DNA Technology
- QIAGEN Reports Strong Third Quarter 2009 Results
- QIAGEN and British Veterinary Laboratories Agency Expand Partnership in Veterinary Testing
- Webcast of QIAGEN N.V.'s (Nasdaq: QGEN) Third Quarter 2009 Financial Results Call Set for November 10
StreetInsider Reports on QGEN by Category
View All BlogsBlogs on QGEN
- Wall Street Breakfast: Must-Know News
- Financing Activity for Biotech Deals Heats Up
- Closing Update for Friday, July 10
- Analyst upgrades, downgrades and initiations: DELL, IBM, IPCR, NETL ...
- Upcoming FDA Decisions and Clinical Trials: Prevacid Goes OTC, Swine Flu Test
View All FilingsSEC Filings on QGEN
- Form 6-K QIAGEN NV For: Sep 30
- Form 6-K QIAGEN NV For: Sep 30
- Form 6-K QIAGEN NV For: Sep 30
- Form 6-K QIAGEN NV For: Sep 28
Comments on QGEN
No comments are currently available.
